Market Overview:
The dermatology diagnostic device market analysis by size, share, emerging trends, application, swot analysis, profile, future insights, global industry analysis and segmentation, forecast to 2022. The global Dermatology Diagnostic Device Market size to register a healthy CAGR during the forecast period (2016-2022). Dermatology diagnostic device market share is expected to witness significant growth due to evolving skin imaging technologies and increased incidences of skin cancer over the forecast period. The penetration of social media, television, and advertising have a tremendous impact on the consumer’s paying attention to aesthetics and physical appearance.
This has, in turn, raised interest in aesthetic surgeries and a variety of cosmetics. Dermatology devices have experienced rapid transformations in the past few years. Skin imaging technologies such as optical coherence tomography (OCT) q-space trajectory imaging (QTI) are extensively in used these days. Terahertz and polarized-light imaging techniques are gaining traction, thereby contributing to the market growth.
Request Free Sample Report at: https://www.marketresearchfuture.com/sample_request/2154
On the contrary, stringent regulatory requirements for medical devices, poor dermatology care, availability of low-cost substitutes, reimbursement issues, and competitive pricing of low-cost manufacturers are some of the major concerns likely to restrict the dermatology diagnostic device market in the foreseeable future.
Dermatology Diagnostic Device Market Competitive Dashboard:
The players operating in the global dermatology diagnostic device market include Alma Lasers, Ltd. (Israel), Valeant Pharmaceuticals (Canada), Lumenis, Ltd. (Israel), Cutera, Inc. (U.S.), Dino-Lite Europe/IDCP B.V., Cynosure, Inc. (U.S.), Michelson Diagnostics Ltd., (UK), Genentech, Inc., (US), Cutera, Inc. (US), and Galderma S.A., (Switzerland).
Global Dermatology Diagnostic Device Market Segmental Analysis
The dermatology diagnostic device market has been segmented on the basis of diagnostic devices, application, and end users.
By diagnostic device, the dermatology diagnostic device market is segmented into imaging devices, dermatoscopes, and microscopes. Of these, the dermatoscopes’ segment is predicted to gain prominence in the coming years.
By application, the dermatology diagnostic device market is segmented into skin cancer, lesion and others.
By end user, the market is segmented into research labs and centers, hospitals, institutions, and others. Of these, the hospitals’ segment is considered to gain prominence due to increasing demand and high availability for advanced dermatological equipment in hospital settings. Availability of several treatment options in hospitals is likely to propel the market growth in the segment.
Dermatology Diagnostic Device Market Regional Insights
Geographically, the dermatology diagnostic device market spans across Europe, America, Asia Pacific, and the Middle East & Africa.
Considering the global scenario, North America is likely to dominate the market due to the surging prevalence of skin disorders like melanoma and psoriasis, soaring awareness regarding aesthetic procedures, and well-developed healthcare infrastructure. Rising awareness associated with aesthetic appeal, availability of advanced treatments, higher consumer disposable income, and increased adoption of cosmetic procedures are augmenting the market growth.
Browse Full Report Details at: https://www.marketresearchfuture.com/reports/dermatology-diagnostic-device-market-2154
The Asia Pacific will gain prominence in the long run, with India and China exhibiting the fastest growth rates. The existence of a large patient population, improving living standards, and surging demand for quality medical care are some of the primary growth stimulants of the regional market. Also, increasing demand for quality medical care, rising awareness regarding healthcare, and increasing expenditure on healthcare will propel the market in the APAC.
Industry Updates
July 2019: Ra Medical Systems, Inc has recently declared that the company has launched Pharos, Optimized, which is considered the next generation of Pharos excimer lasers. It has been specifically designed to improve patient as well as physician experience with faster treatment of vitiligo, psoriasis, and atopic dermatitis.
Brows more healthcare related research reports:
Biopsy Devices Market -
Cardiac Rehabilitation Devices Market -
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
No comments:
Post a Comment